8 completed, 1 terminated. 6 Phase 2, 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 5, Terminated 1 |
| Phase 1 | 3 | Completed 3 |
Follow Provectus Pharmaceuticals: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 2 Study of Cellular and Immunologic Changes in the Skin of Subjects Receiving PH-10 Topical Rose Bengal, 0.005% - Psoriasis | Phase 2 | Completed | Provectus Pharmaceuticals | 30 | 2015-01-01 | 2017-11-13 |
| Detection of Immune Cell Infiltration Into Melanomas Treated by PV-10, a Feasibility Study PV-10, Surgery - Melanoma | Phase 1 | Completed | H. Lee Moffitt Cancer Center and Research Institute | 15 | 2013-01-24 | 2017-04-19 |
| Randomized Study of PH-10 for Psoriasis PH-10 (0.002% Rose Bengal), PH-10 (0.005% Rose Bengal), PH-10 (0.01% Rose Bengal) - Psoriasis | Phase 2 | Completed | Provectus Pharmaceuticals | 99 | 2010-12-01 | 2012-09-28 |
| An Efficacy and Safety Study of PH-10 Aqueous Hydrogel for the Treatment of Plaque Psoriasis PH-10 (0.001% Rose Bengal) - Psoriasis | Phase 2 | Completed | Provectus Pharmaceuticals | 30 | 2009-07-01 | 2010-07-07 |
| A Phase 2 Study of PH-10 for the Treatment of Atopic Dermatitis PH-10 - Atopic Dermatitis | Phase 2 | Completed | Provectus Pharmaceuticals | 30 | 2008-06-01 | 2009-09-28 |
| Topical PH-10 Aqueous Hydrogel and Photodynamic Therapy for Psoriasis PH-10 (rose bengal disodium 0.001%), Control - Plaque Psoriasis | Phase 2 | Terminated | Provectus Pharmaceuticals | 6 | 2007-11-01 | 2021-12-16 |
| Phase 2 Study of Intralesional PV-10 for Metastatic Melanoma PV-10 (10% rose bengal disodium) - Melanoma | Phase 2 | Completed | Provectus Pharmaceuticals | 80 | 2007-09-01 | 2014-08-25 |
| PV-10 Chemoablation of Recurrent Breast Carcinoma PV-10 (rose bengal disodium 10%) - Breast Cancer | Phase 1 | Completed | Provectus Pharmaceuticals | 15 | 2005-10-01 | 2008-10-24 |
| Intralesional PV-10 Chemoablation of Metastatic Melanoma PV-10 (rose bengal disodium, 10%) - Melanoma | Phase 1 | Completed | Provectus Pharmaceuticals | 20 | 2005-08-01 | 2007-08-23 |
Melanoma (3) · Psoriasis (3) · Breast Neoplasms (1) · Dermatitis, Atopic (1) · Eczema (1) · Neoplasm Metastasis (1)
Rose Bengal (6) · Surgical Procedures, Operative (1)
United States (7) · Australia (2) · New Zealand (1)
Eric Wachter, Ph.D. (4) · Alicia Barba, MD (1) · Amir Larian, MD (1) · Amod A. Sarnaik, M.D. (1) · Chris Wynne, M.D. (1) · Eric Wachter, PhD (1) · John F Thompson, MD (1)